Accolade, Inc. (ACCD)
NASDAQ: ACCD · IEX Real-Time Price · USD
12.01
-0.84 (-6.54%)
At close: Dec 29, 2023, 4:00 PM
11.95
-0.06 (-0.50%)
After-hours: Dec 29, 2023, 7:44 PM EST
Accolade Market Cap
Accolade has a market cap or net worth of $915.55 million as of December 29, 2023. Its market cap has increased by 52.59% in one year.
Market Cap
915.55M
Enterprise Value
937.13M
1-Year Change
52.59%
Ranking
Category
Stock Price
$12.01
Market Cap Chart
Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $915.55M, a decrease of -34.41%. That is a compound annual growth rate of -11.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 915.50M | -6.54% |
Dec 28, 2023 | 979.60M | 2.96% |
Dec 27, 2023 | 951.40M | 2.89% |
Dec 26, 2023 | 924.70M | 3.76% |
Dec 22, 2023 | 891.20M | 3.28% |
Dec 21, 2023 | 862.90M | 4.62% |
Dec 20, 2023 | 824.80M | -5.26% |
Dec 19, 2023 | 870.60M | 7.14% |
Dec 18, 2023 | 812.60M | 1.71% |
Dec 15, 2023 | 798.90M | -3.14% |
Dec 14, 2023 | 824.80M | 6.07% |
Dec 13, 2023 | 777.60M | 5.81% |
Dec 12, 2023 | 734.90M | 1.80% |
Dec 11, 2023 | 721.90M | 1.39% |
Dec 8, 2023 | 712.00M | 1.08% |
Dec 7, 2023 | 704.40M | 1.21% |
Dec 6, 2023 | 696.00M | 1.44% |
Dec 5, 2023 | 686.10M | -1.54% |
Dec 4, 2023 | 696.80M | 0.88% |
Dec 1, 2023 | 690.70M | 3.79% |
Nov 30, 2023 | 665.50M | 1.28% |
Nov 29, 2023 | 657.10M | 1.40% |
Nov 28, 2023 | 648.00M | 2.48% |
Nov 27, 2023 | 632.30M | 2.02% |
Nov 24, 2023 | 619.80M | 2.01% |
View and export this data all the way back to 2020.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CARGO Therapeutics | 953.90M |
Cassava Sciences | 949.34M |
CureVac | 942.55M |
MultiPlan | 935.26M |
NewAmsterdam Pharma Company | 919.56M |
Ambrx Biopharma | 899.26M |
Simulations Plus | 893.47M |
4D Molecular Therapeutics | 866.19M |